{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:57:08Z","timestamp":1771480628158,"version":"3.50.1"},"reference-count":36,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Lenalidomide is a thalidomide analog with anti\u2010angiogenic properties. Previous case reports suggest its efficacy in preventing gastrointestinal bleeding (<jats:styled-content style=\"fixed-case\">GIB<\/jats:styled-content>) secondary to angiodysplasia (<jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>) in hereditary haemorrhagic telangiectasia and potentially in reversing <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>. We present the first case series to explore lenalidomide as a treatment for <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>\u2010related <jats:styled-content style=\"fixed-case\">GIB<\/jats:styled-content> in patients with von Willebrand disease (<jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective chart review was conducted to include patients with <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content>, who were evaluated from 2010 to 2013 and who had received lenalidomide to treat recurrent <jats:styled-content style=\"fixed-case\">GIB<\/jats:styled-content> secondary to <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>. All patients had failed single\u2010agent use of antifibrinolytic agents. Patients were observed for at least 2\u00a0years on therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Five patients (3 males; 68.2\u00a0\u00b1\u00a04.9\u00a0years) with <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content> (3 with type 3 and 1 each with types 1 and 2a) and <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content> were found. Sites of <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content> included the stomach, duodenum, jejunum and colon. Lenalidomide was started at 5\u00a0mg oral daily. Uptitration to 10 and 15\u00a0mg in 1 patient each was necessary due to recurrence of <jats:styled-content style=\"fixed-case\">GIB<\/jats:styled-content>. The mean number of endoscopies performed for control of <jats:styled-content style=\"fixed-case\">GIB<\/jats:styled-content> post lenalidomide was significantly lower compared to pretherapy (0.25 vs 5.50; <jats:italic>P<\/jats:italic>\u00a0=\u00a0.001). Mean bleed\u2010free duration on lenalidomide was 12.6\u00a0\u00b1\u00a04.7\u00a0months. Three patients have reported no <jats:styled-content style=\"fixed-case\">GIB<\/jats:styled-content> on lenalidomide.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This case series demonstrates significantly reduced number of endoscopies and increased bleed\u2010free duration with lenalidomide treatment in selected patients with <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content> and recurrent <jats:styled-content style=\"fixed-case\">GIB<\/jats:styled-content> from <jats:styled-content style=\"fixed-case\">AD<\/jats:styled-content>. Prospective multicenter trials are needed to further define the role of lenalidomide in the management of <jats:styled-content style=\"fixed-case\">GIB<\/jats:styled-content> from angiodysplasia and <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hae.13419","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T11:16:38Z","timestamp":1518693398000},"page":"278-282","source":"Crossref","is-referenced-by-count":19,"title":["Lenalidomide as a novel therapy for gastrointestinal angiodysplasia in von Willebrand disease"],"prefix":"10.1111","volume":"24","author":[{"given":"N. V.","family":"Khatri","sequence":"first","affiliation":[{"name":"Georgetown University  Washington DC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1924-0592","authenticated-orcid":false,"given":"B.","family":"Patel","sequence":"additional","affiliation":[{"name":"Medstar Washington Hospital Center  Washington DC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. R.","family":"Kohli","sequence":"additional","affiliation":[{"name":"Medstar Washington Hospital Center  Washington DC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. S.","family":"Solomon","sequence":"additional","affiliation":[{"name":"Howard University Hospital  Washington DC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Bull\u2010Henry","sequence":"additional","affiliation":[{"name":"Georgetown University  Washington DC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Kessler","sequence":"additional","affiliation":[{"name":"Georgetown University  Washington DC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,2,15]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02551967"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.029710"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.13.5979"},{"key":"e_1_2_7_5_1","first-page":"3454","article-title":"Thalidomide therapy for gastrointestinal angiodysplasia","volume":"171","author":"Belard E","year":"2009","journal-title":"Ugeskr Laeger"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07730.x"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01897.x"},{"key":"e_1_2_7_8_1","first-page":"201","article-title":"Changing epidemiology of gastrointestinal angiodysplasia with increasing recognition of clinically milder cases: angiodysplasia tend to produce mild chronic gastrointestinal bleeding in a study of 47 consecutive patients admitted from 1980\u20101989","volume":"87","author":"Cappell MS","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_7_9_1","first-page":"295","article-title":"The mechanisms of thalidomide in treatment of angiodysplasia due to hypoxia","volume":"48","author":"Chen HM","year":"2009","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-0067-z"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01649509"},{"key":"e_1_2_7_12_1","first-page":"1994","article-title":"Thalidomide for the treatment of recurrent gastrointestinal blood loss due to intestinal angiodysplasias","volume":"150","author":"De Koning DB","year":"2006","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_2_7_13_1","first-page":"468","article-title":"Chronic bleeding caused by small bowel angiodysplasia: a problem of recognition and diagnosis","volume":"24","author":"Di Girolamo G","year":"1992","journal-title":"Ital J Gastroenterol"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070594"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2005.01.002"},{"key":"e_1_2_7_16_1","first-page":"16","article-title":"Gastrointestinal angiodysplasia","volume":"8","author":"Dodda G","year":"1997","journal-title":"J Assoc Acad Minor Phys"},{"key":"e_1_2_7_17_1","first-page":"564","article-title":"Prevalence and natural history of colonic angiodysplasia among healthy asymptomatic people","volume":"90","author":"Foutch PG","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-11-0952"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649623"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.07.018"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.22070"},{"key":"e_1_2_7_22_1","first-page":"127","article-title":"Angiodysplasia of the colon: an expression of occlusive vascular disease","volume":"34","author":"Heer M","year":"1987","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_7_23_1","first-page":"425","article-title":"Thalidomide as treatment for digestive tract angiodysplasias","volume":"64","author":"Heidt J","year":"2006","journal-title":"Neth J Med"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1018495"},{"key":"e_1_2_7_25_1","first-page":"333","article-title":"Double\u2010balloon endoscopy in the diagnosis and treatment of hemorrhage from retrovalvular angiodysplasias","volume":"17","author":"Jarbandhan S","year":"2008","journal-title":"J Gastrointestin Liver Dis"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e32832c9346"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1601561"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12008"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041668"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01537107"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199705000-00020"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01954.x"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm9603328"},{"issue":"2","key":"e_1_2_7_34_1","first-page":"s3","article-title":"Role of von Willebrand factor in the haemostasis","volume":"9","author":"Peyvandi F","year":"2011","journal-title":"Blood Transfus"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2007.10.026"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12527"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.4161\/onci.26494"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fhae.13419","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.13419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:14:03Z","timestamp":1695539643000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hae.13419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,15]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1111\/hae.13419"],"URL":"https:\/\/doi.org\/10.1111\/hae.13419","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,15]]}}}